Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Credit agrmnt [a] Acq. announced Director departure
|
VANGUARD HEALTH SYSTEMS INC (VHS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/25/2011 |
8-K
| Quarterly results |
02/07/2011 |
8-K
| Form 8-K - Current report |
11/08/2010 |
8-K
| Quarterly results
Docs:
|
"Vanguard Reports First Quarter Results NASHVILLE, Tenn. — November 8, 2010 — Vanguard Health Systems, Inc. today announced results for the first quarter ended September 30, 2010. Total revenues for the quarter ended September 30, 2010 were $913.9 million, an increase of $94.0 million or 11.5% from the prior year quarter. Patient service revenues increased $77.7 million from the prior year quarter. Health plan premium revenues increased $16.3 million or 8.0% from the prior year quarter. Patient service revenues were positively impacted by Vanguard's August 1, 2010 acquisition of West Suburban Medical Center and Westlake Hospital, both located in the western suburbs of Chicago, Illinois in close proximity to our MacNeal Hospital. Same hospital patient service revenues increased $31.8 million...",
"Adjusted EBITDA Margin",
"Calculation of Certain Financial Covenants under Senior Secured Credit Agreement" |
|
08/25/2010 |
8-K
| Quarterly results |
11/09/2009 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Condensed Consolidated Income Statements Three months ended September 30, 2008 2009 Patient service revenues $ 598.3 83.2 % $ 619.1 75.2 % Premium revenues 120.7 16.8 204.3 24.8 Total revenues 719.0 100.0 823.4 100.0 Costs and Expenses: Salaries and benefits 292.6 40.7 314.4 38.2 Health plan claims expense 87.0 12.1 161.0 19.6 Supplies 111.8 15.5 111.0 13.5 Provision for doubtful accounts 54.6 7.6 37.2 4.5 Purchased services 41.4 5.8 47.6 5.8 Non-income taxes 8.1 1.1 14.2 1.7 Rents and leases 11.2 1.6 11.1 1.4 Other operating expenses 50.5 7.0 60.1 7.3 Depreciation and amortization 32.3 4.5 34.0 4.1 Interest, net 28.7 4.0 27.2 3.3 Other 0.0 1.1 0.1 Total costs and expenses 718.0 99.9 818.9 99.5 Income from continuing operations before income taxes 1.0 0.1 4.5...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income Attributable to Vanguard Stockholders Margin Quarter ended September 30, 2008 2009 Adjusted EBITDA $ 63.2 $ 68.7 Total revenues 719.0 823.4 Adjusted EBITDA Margin 8.8 % 8.3 % Adjusted EBITDA $ 63.2 $ 68.7 Interest, net Income tax expense Depreciation and amortization Non-controlling interests Equity method income – 0.2 Stock compensation Gain on sale of assets 2.1 – Monitoring fees and expenses Realized holding loss on investments – Income from discontinued operations, net of taxes 1.0 Net income attributable to Vanguard stockholders $ 0.9 $ 1.5 Total revenues $ 719.0 $ 823.4 Net in...",
"VANGUARD HEALTH SYSTEMS, INC. Calculation of Certain Financial Covenants under Senior Secured Credit Agreement September 30, 2009 Trailing twelve months ended September 30, 2009 Interest Coverage Ratio Adjusted EBITDA $ 307.9 Add: Equity method cash distributions received 1.1 Less: Minority interest distributions paid Add: Franchise tax expense 0.2 Add: Gross interest income recognized 2.1 Add: Capitalized interest recorded 2.1 Consolidated EBITDA, as defined in senior secured credit agreement $ 308.2 A Net interest $ 110.1 Add: Capitalized interest recorded 2.1 Less: Non-cash accretion of senior discount notes Less: Non-cash amortization of financing costs Less: Interest related to specified construction projects Consolidated cash interest expense, as defined in senior secured credit agre..." |
|
09/01/2009 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Consolidated Statements of Operations Quarter ended June 30, 2008 2009 Patient service revenues $ 600.1 83.7 % $ 632.9 76.2 % Premium revenues 116.5 16.3 197.2 23.8 Total revenues 716.6 100.0 830.1 100.0 Costs and expenses: Salaries and benefits 301.1 42.0 316.4 38.1 Health plan claims expense 85.3 11.9 154.9 18.7 Supplies 111.3 15.5 116.4 14.0 Provision for doubtful accounts 49.4 6.9 55.4 6.7 Purchased services 37.8 5.3 42.4 5.1 Non-income taxes 8.3 1.2 12.5 1.5 Rents and leases 11.1 1.5 11.0 1.3 Other operating expenses 46.6 6.5 47.6 5.7 Depreciation and amortization 34.2 4.8 34.6 4.2 Interest, net 28.7 4.0 27.1 3.3 Impairment loss – 0.0 6.2 0.7 Other 1.9 0.3 1.6 0.2 Total costs and expenses 715.7 99.9 826.1 99.5 Income from continuing operations before inc...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended June 30, Year ended June 30, 2008 2009 2008 2009 Adjusted EBITDA $ 66.3 $ 74.5 $ 266.4 $ 302.4 Total revenues 716.6 830.1 2,790.7 3,199.7 Adjusted EBITDA Margin 9.3 % 9.0 % 9.5 % 9.5 % Adjusted EBITDA $ 66.3 $ 74.5 $ 266.4 $ 302.4 Interest, net Income tax expense Depreciation and amortization Minority interests Gain on disposal of assets 0.2 2.3 Equity method income 0.2 0.4 0.7 0.8 Stock compensation Monitoring fees and expenses Realized loss on investments – – – Impairment loss – – Income from discontinued operations, net of taxes – 0.3 0.9 Net incom...",
"VANGUARD HEALTH SYSTEMS, INC. Calculation of Certain Financial Covenants under Senior Secured Credit Agreement June 30, 2009 Trailing twelve months ended June 30, 2009 Interest Coverage Ratio Adjusted EBITDA $ 302.4 Add: Equity method cash distributions received 1.1 Less: Minority interest distributions paid Add: Franchise tax expense 0.2 Add: Gross interest income recognized 2.4 Add: Capitalized interest recorded 2.0 Consolidated EBITDA, as defined in senior secured credit agreement $ 303.2 A Net interest $ 111.6 Add: Capitalized interest recorded 2.0 Less: Non-cash accretion of senior discount notes Less: Non-cash amortization of financing costs Less: Interest related to specified construction projects Consolidated cash interest expense, as defined in senior secured credit agreement $ 85..." |
|
05/11/2009 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Condensed Consolidated Income Statements Three months ended March 31, 2008 2009 Patient service revenues $ 607.9 83.8 % $ 676.1 78.8 % Premium revenues 117.7 16.2 181.9 21.2 Total revenues 725.6 100.0 858.0 100.0 Costs and Expenses: Salaries and benefits 297.9 41.1 328.4 38.3 Supplies 112.9 15.5 115.3 13.4 Medical claims expense 84.9 11.7 143.0 16.7 Provision for doubtful accounts 53.1 7.3 52.5 6.1 Purchased services 39.6 5.4 43.3 5.0 Rents and leases 10.7 1.5 11.0 1.3 Other operating expenses 52.3 7.2 79.5 9.3 Depreciation and amortization 31.6 4.4 31.6 3.7 Interest, net 29.4 4.1 27.2 3.2 Other 2.2 0.3 1.9 0.2 Total costs and expenses 714.6 98.5 833.7 97.2 Income from continuing operations before income taxes 11.0 1.5 24.3 2.8 Income tax expense 3.5 0.5 8.2 ...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA Margin to Net Income Margin Quarter ended March 31, Nine months ended March 31, 2008 2009 2008 2009 Adjusted EBITDA $ 75.1 $ 86.2 $ 200.1 $ 227.9 Total revenues 725.6 858.0 2,074.1 2,369.6 Adjusted EBITDA Margin 10.4 % 10.0 % 9.6 % 9.6 % Adjusted EBITDA $ 75.1 $ 86.2 $ 200.1 $ 227.9 Interest, net Income tax expense ‑ Depreciation and amortization Minority interests Gain on disposal of assets ‑ 2.1 Equity method income 0.3 0.1 0.5 0.4 Stock compensation Monitoring fees and expenses Realized holding loss on investments ‑ ‑ ‑ Discontinued operations, net of taxes ...",
"VANGUARD HEALTH SYSTEMS, INC. Calculation of Certain Financial Covenants under Senior Secured Credit Agreement March 31, 2009 Trailing twelve months ended March 31, 2009 Interest Coverage Ratio Adjusted EBITDA $ 294.2 Add: Equity method cash distributions received 1.0 Less: Minority interest distributions paid Add: Franchise tax expense 0.1 Add: Gross interest income recognized 2.6 Add: Capitalized interest recorded 1.9 Consolidated EBITDA, as defined in senior secured credit agreement $ 295.0 A Net interest $ 113.2 Add: Capitalized interest recorded 1.9 Less: Non-cash accretion of senior discount notes Less: Non-cash amortization of financing costs Less: Interest related to specified construction projects Consolidated cash interest expense, as defined in senior secured credit agreement $ ..." |
|
02/11/2009 |
8-K
| Form 8-K -- Current report |
11/12/2008 |
8-K
| Quarterly results |
09/22/2008 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Consolidated Statements of Operations Three months ended June 30, 2007 2008 Patient service revenues $ 545.8 83.8 % $ 600.1 83.7 % Premium revenues 105.3 16.2 116.5 16.3 Total revenues 651.1 100.0 716.6 100.0 Costs and expenses: Salaries and benefits 271.4 41.7 301.1 42.0 Supplies 108.4 16.6 111.3 15.5 Medical claims expense 76.7 11.8 85.3 11.9 Provision for doubtful accounts 45.7 7.0 49.4 6.9 Purchased services 32.3 4.9 37.8 5.3 Rents and leases 9.6 1.5 11.1 1.5 Other operating expenses 49.3 7.6 54.9 7.7 Depreciation and amortization 32.3 5.0 34.2 4.8 Interest, net 31.2 4.8 28.7 4.0 Other 1.6 0.2 1.9 0.3 Total costs and expenses 658.5 101.1 715.7 99.9 Income from continuing operations before income taxes 0.9 0.1 Income tax expense 1.7 0.2 Loss from continu...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Loss Margin Quarter ended June 30, Year ended June 30, 2007 2008 2007 2008 Adjusted EBITDA $ 58.2 $ 66.3 $ 245.0 $ 266.4 Total revenues 651.1 716.6 2,580.7 2,790.7 Adjusted EBITDA Margin 8.9 % 9.3 % 9.5 % 9.5 % Adjusted EBITDA $ 58.2 $ 66.3 $ 245.0 $ 266.4 Interest, net Income tax benefit 1.2 11.6 Depreciation and amortization Minority interests Gain on disposal of assets 0.2 4.1 Equity method income 0.1 0.2 0.9 0.7 Stock compensation Monitoring fees and expenses Impairment loss – – – $ $ $ Total revenues $ 651.1 $ 716.6 $ 2,580.7 $ 2,790.7 Net loss margin % % % %" |
|
05/12/2008 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Condensed Consolidated Statements of Operations Three months ended March 31, 2007 2008 Patient service revenues $ 574.8 85.4 % $ 607.9 83.8 % Premium revenues 98.2 14.6 117.7 16.2 Total revenues 673.0 100.0 725.6 100.0 Costs and Expenses: Salaries and benefits and $0.9, respectively) 271.5 40.3 297.9 41.1 Supplies 107.9 16.0 112.9 15.5 Medical claims expense 73.1 10.9 84.9 11.7 Provision for doubtful accounts 45.8 6.8 53.1 7.3 Purchased services 39.0 5.8 39.6 5.4 Rents and leases 9.6 1.4 10.7 1.5 Other operating expenses 51.8 7.7 52.3 7.2 Depreciation and amortization 29.1 4.3 31.6 4.4 Interest, net 31.3 4.7 29.4 4.1 Other 2.2 0.3 Total costs and expenses 656.8 97.6 714.6 98.5 Income from continuing operations before income taxes 16.2 2.4 11.0 1.5 Income tax...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended March 31, Nine months ended March 31, 2007 2008 2007 2008 Adjusted EBITDA $ 74.2 $ 75.1 $ 186.8 $ 200.1 Total revenues 673.0 725.6 1,929.6 2,074.1 Adjusted EBITDA Margin 11.0 % 10.4 % 9.7 % 9.6 % Adjusted EBITDA $ 74.2 $ 75.1 $ 186.8 $ 200.1 Interest, net Income tax benefit 10.4 ‑ Depreciation and amortization Minority interests Gain on disposal of assets 3.9 3.9 Equity method income 0.3 0.3 0.8 0.5 Stock compensation 0.1 Monitoring fees and expenses Impairment loss ‑ ‑ ‑ Discontinued operations, net of taxes Net income $ 3.3 $..." |
|
02/11/2008 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Condensed Consolidated Statements of Operations Three months ended December 31, 2006 2007 Patient service revenues $ 537.4 84.2 % $ 575.7 83.9 % Premium revenues 100.9 15.8 110.3 16.1 Total revenues 638.3 100.0 686.0 100.0 Costs and Expenses: Salaries and benefits 265.4 41.6 280.0 40.8 Supplies 105.3 16.5 107.1 15.6 Medical claims expense 75.5 11.8 82.0 11.9 Provision for doubtful accounts 43.2 6.8 49.2 7.2 Purchased services 36.3 5.7 37.3 5.4 Rents and leases 9.3 1.4 9.9 1.5 Other operating expenses 45.2 7.1 52.8 7.7 Depreciation and amortization 28.3 4.4 32.7 4.8 Interest, net 31.5 4.9 32.3 4.7 Impairment loss 123.8 19.4 – 0.0 Other 4.3 0.7 3.4 0.5 Total costs and expenses 768.1 120.3 686.7 100.1 Loss from continuing operations before income taxes Income ...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended December 31, Six months ended December 31, 2006 2007 2006 2007 Adjusted EBITDA $ 58.6 $ 68.2 $ 112.6 $ 125.0 Total revenues 638.3 686.0 1,256.6 1,348.5 Adjusted EBITDA Margin 9.2 % 9.9 % 9.0 % 9.3 % Adjusted EBITDA $ 58.6 $ 68.2 $ 112.6 $ 125.0 Interest, net Income tax benefit 15.0 0.1 16.5 3.5 Depreciation and amortization Minority interests Loss on disposal of assets ‑ Equity method income 0.3 0.5 0.2 Stock compensation Monitoring fees and expenses Impairment loss ‑ ‑ Discontinued operations, net of taxes 1.1 0.7 Net income $ $ 0.5 ..." |
|
11/13/2007 |
8-K
| Quarterly results |
09/18/2007 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Consolidated Statements of Operations Three months ended June 30, 2006 2007 Patient service revenues $ 521.0 83.8 % $ 545.8 83.8 % Premium revenues 100.8 16.2 105.3 16.2 Total revenues 621.8 100.0 651.1 100.0 Costs and expenses: Salaries and benefits 253.6 40.8 271.3 41.7 Supplies 101.2 16.3 108.4 16.6 Medical claims expense 73.6 11.8 76.7 11.8 Provision for doubtful accounts 37.1 6.0 45.7 7.0 Purchased services 35.6 5.7 32.3 4.9 Rents and leases 9.1 1.5 9.6 1.5 Other operating expenses 54.0 8.7 49.4 7.6 Depreciation and amortization 30.9 4.9 32.3 5.0 Interest, net 26.7 4.3 31.1 4.8 Other expenses 4.6 0.7 1.6 0.2 Total costs and expenses 626.4 100.7 658.4 101.1 Loss from continuing operations before income taxes Income tax benefit Loss from continuing ope...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended June 30, Year ended June 30, 2006 2007 2006 2007 Adjusted EBITDA $ 58.2 $ 58.2 $ 254.7 $ 245.0 Total revenues 621.8 651.1 2,418.6 2,580.7 Adjusted EBITDA Margin 9.4 % 8.9 % 10.5 % 9.5 % Adjusted EBITDA $ 58.2 $ 58.2 $ 254.7 $ 245.0 Interest, net Income tax benefit 2.1 1.7 11.6 Depreciation and amortization Minority interests Gain on disposal of assets 0.2 4.1 Equity method income 0.1 0.2 0.9 Stock compensation Debt extinguishment costs ‑ ‑ ‑ Monitoring fees Impairment loss ‑ ‑ ‑ Loss from discontinued operations, net..." |
|
05/08/2007 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Condensed Consolidated Statements of Operations Three months ended March 31, 2006 2007 Patient service revenues $ 538.4 84.5 % $ 586.3 85.7 % Premium revenues 98.7 15.5 98.2 14.3 Total revenues 637.1 100.0 684.5 100.0 Costs and Expenses: Salaries and benefits , respectively) 261.1 41.0 279.1 40.8 Supplies 105.4 16.5 109.7 16.0 Medical claims expense 74.3 11.7 73.1 10.7 Provision for doubtful accounts 42.7 6.7 47.2 6.9 Purchased services 32.6 5.1 40.1 5.9 Rents and leases 9.2 1.5 9.8 1.4 Other operating expenses 41.6 6.5 53.3 7.8 Depreciation and amortization 24.1 3.8 29.5 4.3 Interest, net 26.1 4.1 31.6 4.6 Other 1.1 0.2 0.3 0.0 Total costs and expenses 618.2 97.1 673.7 98.4 Income from continuing operations before income taxes 18.9 2.9 10.8 1.6 Income tax ex...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended March 31, Nine months ended March 31, 2006 2007 2006 2007 Adjusted EBITDA $ 70.7 $ 72.1 $ 197.2 $ 183.6 Total revenues 637.1 684.5 1,840.6 1,972.3 Adjusted EBITDA Margin 11.1 % 10.5 % 10.7 % 9.3 % Adjusted EBITDA $ 70.7 $ 72.1 $ 197.2 $ 183.6 Interest, net Income tax benefit 13.1 Depreciation and amortization Minority interests Gain on sale of assets 0.9 1.3 0.9 1.2 Equity method income 0.1 0.3 0.9 0.9 Stock compensation 0.1 Debt extinguishment costs ‑ ‑ ‑ Monitoring fees Impairment loss ‑ ‑ ‑ Discontinued operations..." |
|
02/12/2007 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Condensed Consolidated Statements of Operations Three months ended December 31, 2005 2006 Patient service revenues $ 508.5 85.0 % $ 552.0 84.5 % Premium revenues 89.4 15.0 100.9 15.5 Total revenues 597.9 100.0 652.9 100.0 Costs and Expenses: Salaries and benefits 252.4 42.2 273.8 41.9 Supplies 97.1 16.3 108.3 16.6 Medical claims expense 63.0 10.5 75.5 11.6 Provision for doubtful accounts 35.8 6.0 45.3 6.9 Purchased services 31.6 5.3 37.3 5.7 Rents and leases 8.3 1.4 9.5 1.5 Other operating expenses 48.8 8.1 46.5 7.1 Depreciation and amortization 23.3 3.9 28.8 4.4 Interest, net 26.4 4.4 31.7 4.9 Impairment expense – 0.0 123.8 19.0 Other 2.0 0.3 4.3 0.6 Total costs and expenses 588.7 98.4 784.8 120.2 Income from continuing operations before income taxes 9.2 1.6...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended December 31, Six months ended December 31, 2005 2006 2005 2006 Adjusted EBITDA $ 61.2 $ 57.2 $ 126.5 $ 111.5 Total revenues 597.9 652.9 1,203.5 1,287.8 Adjusted EBITDA Margin 10.2 % 8.8 % 10.5 % 8.7 % Adjusted EBITDA $ 61.2 $ 57.2 $ 126.5 $ 111.5 Interest, net Income tax benefit 15.7 17.3 Depreciation and amortization Minority interests Gain on sale of assets 0.1 ‑ Equity method income 0.2 0.3 0.8 0.6 Stock compensation Debt extinguishment costs ‑ ‑ Monitoring fees Impairment expense ‑ ‑ Discontinued operations, net of tax..." |
|
11/08/2006 |
8-K
| Quarterly results |
09/19/2006 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Consolidated Statements of Operations Three months ended June 30, 2005 2006 Patient service revenues $ 545.7 86.3 % $ 581.7 85.2 % Premium revenues 86.7 13.7 100.8 14.8 Total revenues 632.4 100.0 682.5 100.0 Costs and Expenses: Salaries and benefits 268.8 42.5 287.0 42.0 Supplies 105.4 16.7 110.1 16.1 Medical claims expense 58.1 9.2 73.6 10.8 Provision for doubtful accounts 41.1 6.5 42.4 6.2 Other operating expenses 94.2 14.9 110.0 16.1 Depreciation and amortization 29.0 4.6 33.0 4.9 Interest, net 26.0 4.1 28.6 4.2 Merger expenses 0.1 0.0 – 0.0 Impairment expense – 0.0 15.0 2.2 Other 0.7 0.1 4.6 0.7 Total costs and expenses 623.4 98.6 704.3 103.2 Income before income taxes 9.0 1.4 Income tax expense 1.2 0.2 Net income $ 7.8 1.2 % $ % VANGUARD HEALTH SYSTEMS...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA Margin to Net Income/Loss Margin Quarter ended June 30, Year ended June 30, 2005 2006 2005 2006 Adjusted EBITDA $ 65.1 $ 60.0 $ 244.8 $ 256.6 Total revenues 632.4 682.5 2,268.9 2,652.7 Adjusted EBITDA Margin 10.3 % 8.8 % 10.8 % 9.7 % Adjusted EBITDA $ 65.1 $ 60.0 $ 244.8 $ 256.6 Interest, net Income tax benefit 8.2 33.6 Depreciation and amortization Minority interests 0.4 Gain on sale of assets 0.4 9.6 Equity method income 0.3 0.9 0.1stock compensation Debt extinguishment costs ‑ ‑ Merger expenses ‑ ‑ Impairment expense ‑ ‑ Monitoring fees Net income $ 7...." |
|
05/11/2006 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Consolidated Statements of Operations Three months ended March 31, 2005 2006 Patient service revenues $ 559.3 87.0 % $ 582.1 85.5 % Premium revenues 83.7 13.0 98.7 14.5 Total revenues 643.0 100.0 680.8 100.0 Costs and Expenses: Salaries and benefits 271.6 42.2 285.5 41.9 Supplies 108.8 16.9 111.4 16.4 Medical claims expense 62.2 9.7 74.3 10.9 Provision for doubtful accounts 40.2 6.3 46.3 6.8 Other operating expenses 86.9 13.5 93.5 13.7 Depreciation and amortization 13.1 2.0 25.5 3.8 Interest, net 25.4 4.0 27.8 4.1 Merger expenses 0.1 0.0 – 0.0 Other 1.5 0.2 Total costs and expenses 609.8 94.8 654.3 96.1 Income before income taxes 33.2 5.2 26.5 3.9 Income tax expense 13.6 2.1 10.9 1.6 Net income $ 19.6 3.1 % $ 15.6 2.3 % VANGUARD HEALTH SYSTEMS, INC. Consolid...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended March 31, Nine months ended March 31, 2005 2006 2005 2006 Adjusted EBITDA $ 73.5 $ 70.3 $ 179.7 $ 196.6 Total revenues 643.0 680.8 1,636.5 1,970.2 Adjusted EBITDA Margin 11.4 % 10.3 % 11.0 % 10.0 % Adjusted EBITDA $ 73.5 $ 70.3 $ 179.7 $ 196.6 Interest, net Income tax benefit 34.8 Depreciation and amortization Minority interests 0.5 Gain on sale of assets 12.0 12.0 Equity method income 0.3 ‑ 0.6 0.8 Stock compensation Debt extinguishment costs ‑ ‑ Merger expenses ‑ ‑ Monitoring fees Net income $ 19.6 $ 15.6 $ $ 26.5 Total ..." |
|
02/08/2006 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Consolidated Statements of Operations Three months ended December 31, 2004 2005 Patient service revenues $ 416.1 83.3 % $ 552.3 86.1 % Premium revenues 83.7 16.7 89.4 13.9 Total revenues 499.8 100.0 641.7 100.0 Costs and Expenses: Salaries and benefits 200.4 40.1 276.5 43.1 Supplies 80.6 16.1 102.8 16.0 Medical claims expense 56.6 11.3 63.0 9.8 Provision for doubtful accounts 35.5 7.1 39.3 6.1 Other operating expenses 72.7 14.6 99.5 15.5 Depreciation and amortization 20.8 4.2 24.5 3.8 Interest, net 25.0 5.0 28.2 4.4 Debt extinguishment costs – 0.0 0.1 0.1 Other 1.1 0.2 2.0 0.3 Total costs and expenses 492.7 98.6 635.9 99.1 Income before income taxes 7.1 1.4 5.8 0.9 Income tax expense 2.5 0.5 2.2 0.3 Net income $ 4.6 0.9 % $ 3.6 0.6 % VANGUARD HEALTH SYSTEMS, ...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income/Loss Margin Quarter ended December 31, Six months ended December 31, 2004 2005 2004 2005 Adjusted EBITDA $ 54.2 $ 60.8 $ 106.2 $ 126.3 Total revenues 499.8 641.7 993.5 1,289.4 Adjusted EBITDA Margin 10.8 % 9.5 % 10.7 % 9.8 % Adjusted EBITDA $ 54.2 $ 60.8 $ 106.2 $ 126.3 Interest, net Income tax benefit 48.4 Depreciation and amortization Minority interests 0.3 0.8 Gain on sale of assets 0.1 ‑ Equity method income 0.1 0.2 0.3 0.8 Stock compensation Debt extinguishment costs ‑ Merger expenses ‑ ‑ ‑ Monitoring fees Net income $ 4.6 $ 3.6 $ $ 10.9 Total ..." |
|
11/08/2005 |
8-K
| Quarterly results |
09/12/2005 |
8-K
| Quarterly results |
05/09/2005 |
8-K
| Quarterly results |
02/09/2005 |
8-K
| Quarterly results |
08/09/2004 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Consolidated Income Statements Three months ended June 30, 2003 2004 Patient service revenues $ 346.0 85.9 % $ 389.0 82.9 % Premium revenues 56.9 14.1 80.2 17.1 Total revenues 402.9 100.0 469.2 100.0 Costs and Expenses: Salaries and benefits 176.1 43.7 191.6 40.8 Supplies 64.9 16.1 75.5 16.1 Medical claims expense 42.0 10.4 55.1 11.7 Provision for doubtful accounts 21.6 5.4 28.5 6.1 Insurance 7.3 1.8 7.9 1.7 Other expenses 57.3 14.2 60.3 12.9 Depreciation and amortization 14.9 3.7 18.0 3.8 Interest, net 10.0 2.5 10.7 2.3 Debt extinguishment costs – 0.0 4.9 1.0 Total costs and expenses 394.1 97.8 452.5 96.4 Income before income taxes 8.8 2.2 16.7 3.6 Income tax expense 3.5 0.9 6.5 1.4 Net income 5.3 1.3 10.2 2.2 Preferred dividends Net income attributable to...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income Margin Quarter ended June 30, Year ended June 30, 2003 2004 2003 2004 Adjusted EBITDA $ 33.7 $ 51.2 $ 108.7 $ 173.0 Total revenues 402.9 469.2 1,340.5 1,782.8 Adjusted EBITDA Margin 8.4 % 10.9 % 8.1 % 9.7 % Adjusted EBITDA $ 33.7 $ 51.2 $ 108.7 $ 173.0 Interest, net Income tax expense Depreciation and amortization Minority interests 0.2 2.5 Equity method income 0.4 1.6 1.5 Non-cash stock compensation ‑ ‑ ‑ Gain on sale of assets ‑ ‑ 0.8 Debt extinguishment costs ‑ ‑ Net income $ 5.3 $ 10.2 $ 16.9 $ 40.1 Total revenues $ 402.9 $ 469.2 $ 1,340..." |
|
05/10/2004 |
8-K
| Quarterly results
Docs:
|
"VANGUARD HEALTH SYSTEMS, INC. Condensed Consolidated Income Statements Three months ended March 31, 2003 2004 Patient service revenues $ 348.4 86.6 % $ 385.0 83.4 % Premium revenues 54.0 13.4 76.7 16.6 Total revenues 402.4 100.0 461.7 100.0 Costs and Expenses: Salaries and benefits 175.3 43.5 190.2 41.2 Supplies 66.3 16.5 73.7 15.9 Medical claims expense 40.5 10.1 55.8 12.1 Provision for doubtful accounts 24.2 6.0 29.4 6.4 Insurance 8.5 2.1 9.5 2.1 Other expenses 53.7 13.4 54.6 11.8 Depreciation and amortization 12.9 3.2 15.7 3.4 Interest, net 10.4 2.6 11.1 2.4 Total costs and expenses 391.8 97.4 440.0 95.3 Income before income taxes 10.6 2.6 21.7 4.7 Income tax expense 4.0 1.0 7.9 1.7 Net income 6.6 1.6 13.8 3.0 Preferred dividends Net income attributable to common stockholders $ 5.7 1...",
"Vanguard Health Systems, Inc. Supplementary Financial Information Adjusted EBITDA Margin Presentation of Most Directly Comparable GAAP Financial Measure and Reconciliation of Adjusted EBITDA to Net Income Margin Quarter ended March 31, Nine months ended March 31, 2003 2004 2003 2004 Adjusted EBITDA $ 32.9 $ 47.4 $ 75.0 $ 121.8 Total revenues 402.4 461.7 937.6 1,313.6 Adjusted EBITDA Margin 8.2 % 10.3 % 8.0 % 9.3 % Adjusted EBITDA $ 32.9 $ 47.4 $ 75.0 $ 121.8 Interest, net Income tax expense Depreciation and amortization Minority interests 0.1 0.4 2.3 Equity method income 1.0 0.8 1.2 2.6 Non-cash stock compensation ‑ ‑ Gain on sale of assets ‑ 0.1 0.8 Net income $ 6.6 $ 13.8 $ 11.6 $ 29.9 Total revenues $ 402.4 $ 461.7 $ 937.6 $ 1,313.6 Net income margin 1.6 % 3.0 % ..." |
|
02/09/2004 |
8-K
| Quarterly results |
11/10/2003 |
8-K
| Quarterly results |
09/22/2003 |
8-K
| Quarterly results |
|
|